BESPOKE CRC: The Impact of ctDNA-Guided Therapy in CRC
Focusing on the BESPOKE CRC study, John H. Strickler, MD, reviews recent updates presented at ASGO GI 2024 and discusses subset analyses from the trial.
The Study Design and Early Findings from the INTERCEPT Study in CRC
An overview of the rationale and study design of the INTERCEPT study in patients with colorectal cancer, with a focus on the early key findings.
Non-Clear Cell RCC: Key Learnings and Future Research Directions
March 26th 2024The panel discusses key learnings from recent studies in non-clear cell RCC subtypes and the need to better understand disease biology to develop optimized, histology-specific therapies rather than extrapolating clear cell treatment approaches.